Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Ps Multiple | 3.6x - 3.9x | 3.7x |
| Selected Fwd Ps Multiple | 2.9x - 3.2x | 3.0x |
| Fair Value | ﷼16.84 - ﷼18.62 | ﷼17.73 |
| Upside | -12.7% - -3.5% | -8.1% |
| Benchmarks | Ticker | Full Ticker |
|---|---|---|
| National Medical Care Company | 400,500.0% | SASE:4005 |
| Naba Al Saha Medical Services Company | 954,600.0% | SASE:9546 |
| Al Hammadi Holding Company | 400,700.0% | SASE:4007 |
| Dr. Sulaiman Al Habib Medical Services Group Company | 401,300.0% | SASE:4013 |
| Al-Modawat Specialized Medical Company | 959,400.0% | SASE:9594 |
| Twareat Medical Care Company | 962,700.0% | SASE:9627 |
| Select Price / LTM Sales Ratio | ||||||||
| Benchmark Companies | ||||||||
| 4005 | 9546 | 4007 | 4013 | 9594 | 9627 | |||
| SASE:4005 | SASE:9546 | SASE:4007 | SASE:4013 | SASE:9594 | SASE:9627 | |||
| Historical Sales Growth | ||||||||
| 5Y CAGR | 12.8% | NM- | 3.4% | 17.4% | NM- | NM- | ||
| 3Y CAGR | 15.2% | 18.2% | 6.6% | 15.6% | NM- | NM- | ||
| Latest Twelve Months | 23.4% | 6.5% | 2.0% | 21.7% | 5.7% | 24.0% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | 18.0% | 21.9% | 20.5% | 20.0% | 18.3% | 12.7% | ||
| Prior Fiscal Year | 22.3% | 28.7% | 25.8% | 21.5% | 17.6% | 9.2% | ||
| Latest Fiscal Year | 23.0% | 11.2% | 29.4% | 20.7% | 25.0% | 12.3% | ||
| Latest Twelve Months | 21.9% | 11.2% | 29.6% | 19.6% | 14.6% | 12.3% | ||
| Current Trading Multiples | ||||||||
| EV / LTM EBITDA | 20.6x | 21.8x | 15.4x | 35.2x | 24.9x | 27.4x | ||
| Price / LTM Sales | 5.3x | 3.6x | 5.1x | 7.9x | 5.5x | 4.0x | ||
| LTM P/E Ratio | 24.2x | 32.3x | 17.3x | 40.5x | 37.9x | 32.8x | ||
| Low | Mid | High | ||||||
| Benchmark LTM P/S Ratio | 3.6x | 5.3x | 7.9x | |||||
| Historical LTM P/S Ratio | 4.0x | 4.0x | 4.0x | |||||
| Selected Price / Sales Multiple | 3.6x | 3.7x | 3.9x | |||||
| (x) LTM Sales | 192 | 192 | 192 | |||||
| (=) Equity Value | 682 | 718 | 754 | |||||
| (/) Shares Outstanding | 40.0 | 40.0 | 40.0 | |||||
| Implied Value Range | 17.05 | 17.94 | 18.84 | |||||
| FX Rate: SAR/SAR | 1.0 | 1.0 | 1.0 | Market Price | ||||
| Implied Value Range (Trading Cur) | 17.05 | 17.94 | 18.84 | 19.30 | ||||
| Upside / (Downside) | -11.7% | -7.0% | -2.4% | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | 4005 | 9546 | 4007 | 4013 | 9594 | 9627 | |
| Value of Common Equity | 7,320 | 704 | 6,032 | 93,940 | 411 | 772 | |
| (/) Shares Outstanding | 44.7 | 10.5 | 160.0 | 350.0 | 23.8 | 40.0 | |
| Implied Stock Price | 163.80 | 67.00 | 37.70 | 268.40 | 17.32 | 19.30 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 163.80 | 67.00 | 37.70 | 268.40 | 17.32 | 19.30 | |
| Trading Currency | SAR | SAR | SAR | SAR | SAR | SAR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |